Ligand Pharmaceuticals (LGND) Shares Repurchased (2011 - 2020)

Ligand Pharmaceuticals' Shares Repurchased history runs 8 years deep, the most recent figure standing at $4.7 million for Q4 2020.

• In Q4 2020, Shares Repurchased fell 94.25% year-over-year to $4.7 million; the TTM figure through Sep 2021 stood at $4.7 million (down 96.97% YoY), while the FY2025 annual figure was $15.0 million, changed N/A from the prior year.
• Shares Repurchased came in at $4.7 million for Q4 2020 at Ligand Pharmaceuticals, down from $73.3 million in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $181.2 million in Q3 2019 to a low of $502000.0 in Q1 2016.
• A 5-year average of $59.7 million and a median of $50.8 million in 2018 frame the typical range for Shares Repurchased.
• Across the five-year window, Shares Repurchased soared 7899.21% in 2019 and tumbled 94.25% in 2020, its largest moves.
• Ligand Pharmaceuticals' Shares Repurchased stood at $502000.0 in 2016, then jumped by 291.63% to $2.0 million in 2017, then jumped by 3467.7% to $70.1 million in 2018, then climbed by 16.82% to $81.9 million in 2019, then sank by 94.25% to $4.7 million in 2020.
• According to Business Quant data, Shares Repurchased over the past three periods registered $4.7 million, $73.3 million, and $81.9 million for Q4 2020, Q1 2020, and Q4 2019 respectively.

Peer Comparison